Wire Stories
Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences� Anti-TIGIT Program in Japan and Certain Territories in Asia
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with...